Opening the central research laboratory: seeding fermentation into genetics (1970)
The gamble of investing in what will not pay soon
The core of this decision is that in the hardest period, the investment chosen was the one furthest from recovery. Committing running costs greater than ordinary profit to a laboratory is difficult to justify on the finances of the time. That Omiya Takashi could nonetheless override the objections was, it seems, because a conviction about the fermentation technology gained in brewing coincided with a fear that contraction alone would leave the company thin. The rhythm of management that decided withdrawal and investment in the same period tells you the character of this judgment.
But to praise this only as foresight, on the grounds that the investment reached as far as the peak of PCR demand half a century later, simplifies the story too much. It took nearly twenty years for the laboratory to produce results, and in between lay patient basic research and the accumulated judgments of the managers who followed. When a single investment bears fruit as a business after a long passage of time, it requires as much decision to continue as the first decision took. The history of the central laboratory says that quietly.
Revenue and net margin, FY1965–FY1975
Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY1970 onwards — after it was taken.
Source: securities reports
Read the full dossier in Japanese →
The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.
Other key decisions at Takara Holdings
- 1967 Exiting beer and selling two plants to Kirin and Sapporo (1967)
- 1986 Buying foreign liquor brands while shochu was still strong (1986)
- 2002 Splitting liquor and biotech under a holding company (2002)
- 2017 Making overseas Japanese-food distribution the growth engine (2017)
- 2026 Taking Takara Bio fully private to end the parent-subsidiary listing (2026)
Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →
Disclaimer
- This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
- Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
- Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
- Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
- Company names, logos and other marks belong to their respective owners.
Data API
Takara Holdings’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
| Method | Endpoint | Returns |
|---|---|---|
| GET | /api/companies.json | All companies |
| GET | /api/2531/manifest.json | Resource index |
| GET | /api/2531/history.json | History overview |
| GET | /api/2531/timeline.json | Chronology |
| GET | /api/decisions.json | All management decisions (index) |
| GET | /api/2531/decisions.json | Management decisions (index) |
| GET | /api/2531/decisions/{slug}.json | One decision (full dossier) |
| GET | /api/2531/executives.json | Executives |
| GET | /api/2531/shareholders.json | Major shareholders |
| GET | /api/2531/financials.json | Financial statements |
| GET | /api/2531/financials-longterm.json | Long-term results |
| GET | /api/2531/segments.json | Business segments |
| GET | /api/2531/regions.json | Sales by region |
| GET | /api/2531/workforce.json | Workforce |